INS and metabolic disease: Even though ERS and TLRs activation have been originally studied as independent mechanisms in the pathophysiology of metabolic disorders, there is a considerable body of evidence suggesting a constant crosstalk between them in the modulation of metabolic dysfunction and inflammation associated to a decreased insulin sensitivity and downstream actions (Guillemot-Legris and Muccioli, 2017).